gadolinium dtpa has been researched along with phenylephrine in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewitt, DS; Hillman, GR; Kent, TA; Mottet, I; Perez-Polo, JR; Quast, MJ; Uhrbrock, DH; Wei, J | 1 |
1 other study(ies) available for gadolinium dtpa and phenylephrine
| Article | Year |
|---|---|
NG-nitro-L-arginine methyl ester modifies the input function measured by dynamic susceptibility contrast magnetic resonance imaging.
Topics: Animals; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Enzyme Inhibitors; Gadolinium DTPA; Indicator Dilution Techniques; Magnetic Resonance Imaging; Male; Meglumine; Models, Theoretical; NG-Nitroarginine Methyl Ester; Nitroprusside; Organometallic Compounds; Pentetic Acid; Phenylephrine; Rats; Rats, Sprague-Dawley; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 1997 |